Analyze tumor genetic changes to understand lung cancer resistance
Part of Cancer, Lungs & breathing clinical trials.
This study looks at lung cancer tumor tissue to find genetic “on/off” changes and why treatments may stop working. It may help your care team choose better next tests or treatments based on what the tumor is doing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re being evaluated or treated for a chest (thoracic) cancer, such as lung cancer
- You are age 18 or older
- You either have planned standard tests/procedures where tumor samples can be taken (like CT-guided biopsy or thoracentesis), or you already have stored tumor tissue from a past biopsy or surgery
- The tumor sample must be suitable for genetic testing of “oncogenes” and resistance mechanisms
- You can understand the study and are willing to sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic changes in people with suspected or high-risk lung cancer. It aims to use those results to guide more personalized treatment decisions.
This study collects and analyzes lung cancer tissue samples to understand genetic differences that may help guide future treatment. You'll provide a tissue sample (either from a biopsy or prior surgery), and researchers will study it—no treatment is given in this study.
This trial uses advanced gene sequencing technology on blood and tumor tissue samples from people with non-small cell lung cancer. The goal is to see if this testing can help doctors better predict which treatments will work and detect if the cancer comes back early.
This study looks at gene-related information from a lung tumor sample and pairs it with special imaging to better understand non-small cell lung cancer. If you have a confirmed diagnosis and the right samples/tests, this may help researchers match patients to the most useful information for planning treatment.
This trial collects tissue samples from your lung tumor and any tumors that have spread to other parts of your body. They will study the genetic makeup of these samples to better understand lung cancer and improve future treatments.
This study looks at lung cancer tumor samples and blood to find DNA changes (gene changes) that may be driving the cancer. The results could help researchers better understand lung cancer and guide future treatments.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.